A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
for Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
4 locations incl. Washington D.C.
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All·Age: 18+
Code: NCT07407933·Phase 1, Phase 2·Recruiting